Adam T Phillips1, Stacie Deiner2, Hung Mo Lin3, Evie Andreopoulos3, Jeffrey Silverstein4, Matthew A Levin5. 1. Department of Internal Medicine, School of Medicine, Yale University, New Haven, Connecticut. 2. Department of Anesthesiology, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Geriatrics and Palliative Care, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: stacie.deiner@mountsinai.org. 3. Department of Health Evidence and Policy, Icahn School of Medicine at Mount Sinai, New York, New York. 4. Department of Anesthesiology, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Geriatrics and Palliative Care, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Health Evidence and Policy, Icahn School of Medicine at Mount Sinai, New York, New York. 5. Department of Anesthesiology, Icahn School of Medicine at Mount Sinai, New York, New York.
Abstract
PURPOSE: Geriatric patients are more sensitive to the anesthetic effects of propofol and its adverse effects, such as hypotension, than is the general population; thus, a reduced dose (1-1.5 mg/kg) is recommended for the induction of anesthesia. The extent to which clinicians follow established dosing guidelines has not been well described. Therefore, we investigated the prevalence of propofol overdose in the elderly population to determine whether propofol overdose occurs and is associated with increased hypotension and 30-day mortality. METHODS: In this retrospective study in patients who received propofol for the induction of general anesthesia, data on demographic characteristics, preoperative medications, intraoperative management, and 30-day mortality were collected. The dose of propofol used for the induction of anesthesia and the median blood pressure in the pre- and immediate postinduction periods were determined. Hypotension was defined as either: (1) a decrease in mean arterial pressure (MAP) of >40% concurrent with a MAP of <70 mm Hg; or (2) a MAP of <60 mm Hg. FINDINGS: A total of 17,540 patients were included in the analysis; 4033 (23.0%) were aged >65 years. The median (interquartile range) propofol dose in the group aged >65 years was 1.8 (1.4-2.2) mg/kg, above the recommended dose, in comparison to 2.2 (1.9-2.5) mg/kg in younger patients. On multivariate analysis, increased propofol dose was associated with increased postinduction hypotension, especially in patients over 70 years of age, but not 30-day mortality. IMPLICATIONS: Older patients received greater-than-recommended doses of propofol for induction, which may have led to significant dose-dependent hypotension. Despite this finding, the dose of propofol for induction was not independently associated with a greater 30-day mortality rate. More education regarding geriatric concerns is needed for encouraging anesthesiologists to tailor the plan for anesthesia in geriatric patients. However, overall postsurgical mortality is a function of preoperative risk and type surgical procedure.
PURPOSE: Geriatric patients are more sensitive to the anesthetic effects of propofol and its adverse effects, such as hypotension, than is the general population; thus, a reduced dose (1-1.5 mg/kg) is recommended for the induction of anesthesia. The extent to which clinicians follow established dosing guidelines has not been well described. Therefore, we investigated the prevalence of propofoloverdose in the elderly population to determine whether propofoloverdose occurs and is associated with increased hypotension and 30-day mortality. METHODS: In this retrospective study in patients who received propofol for the induction of general anesthesia, data on demographic characteristics, preoperative medications, intraoperative management, and 30-day mortality were collected. The dose of propofol used for the induction of anesthesia and the median blood pressure in the pre- and immediate postinduction periods were determined. Hypotension was defined as either: (1) a decrease in mean arterial pressure (MAP) of >40% concurrent with a MAP of <70 mm Hg; or (2) a MAP of <60 mm Hg. FINDINGS: A total of 17,540 patients were included in the analysis; 4033 (23.0%) were aged >65 years. The median (interquartile range) propofol dose in the group aged >65 years was 1.8 (1.4-2.2) mg/kg, above the recommended dose, in comparison to 2.2 (1.9-2.5) mg/kg in younger patients. On multivariate analysis, increased propofol dose was associated with increased postinduction hypotension, especially in patients over 70 years of age, but not 30-day mortality. IMPLICATIONS: Older patients received greater-than-recommended doses of propofol for induction, which may have led to significant dose-dependent hypotension. Despite this finding, the dose of propofol for induction was not independently associated with a greater 30-day mortality rate. More education regarding geriatric concerns is needed for encouraging anesthesiologists to tailor the plan for anesthesia in geriatric patients. However, overall postsurgical mortality is a function of preoperative risk and type surgical procedure.
Authors: Daniel I Sessler; Jeffrey C Sigl; Scott D Kelley; Nassib G Chamoun; Paul J Manberg; Leif Saager; Andrea Kurz; Scott Greenwald Journal: Anesthesiology Date: 2012-06 Impact factor: 7.892
Authors: C C Hug; C H McLeskey; M L Nahrwold; M F Roizen; T H Stanley; R A Thisted; C A Walawander; P F White; J L Apfelbaum; T H Grasela Journal: Anesth Analg Date: 1993-10 Impact factor: 5.108
Authors: Felipe L Malafaia; Patrícia O Guimarães; Márcio C Sampaio; Pedro G M de Barros E Silva; Renato D Lopes; Juliano V Custódio; Miguel da S Diniz; José C T Garcia; Valter Furlan Journal: J Geriatr Cardiol Date: 2019-12 Impact factor: 3.327
Authors: Eric Y Chen; George Michel; Bin Zhou; Feng Dai; Shamsuddin Akhtar; Robert B Schonberger Journal: Drugs Aging Date: 2020-06 Impact factor: 3.923
Authors: Robert B Schonberger; Amit Bardia; Feng Dai; George Michel; David Yanez; Jeptha P Curtis; Michelle T Vaughn; Matthew M Burg; Michael Mathis; Sachin Kheterpal; Shamsuddin Akhtar; Nirav Shah Journal: J Am Geriatr Soc Date: 2021-03-31 Impact factor: 7.538